Feldan Therapeutics is a clinical-stage pharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics. 

Feldan strives to improve the quality of patients’ lives by developing breakthrough treatments acting within the cells.

We have designed the Feldan Shuttle, a unique peptide-based technology that gives access to targets beyond the reach of existing drugs.

Feldan is a clinical-stage pharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Feldan is behind the design of a proprietary peptide-based technology that enables safe and efficient delivery of various compounds inside cells and hence unlocks the development of a new generation of therapies. Feldan’s pipeline focuses on diseases affecting lungs and skin.

Our team is composed of passionate and highly qualified individuals with combined expertise in chemical engineering, biochemistry, cellular biology, clinical development, business and finance. 

We are owners of Feldan’s future. We stake our reputation on the excellence of our work and take ownership of everything we do to meet our business needs, improve our systems and help others grow. We are Feldan!

Feldan Therapeutics is supported by a group of firms that contribute to the success of our mission